Literature DB >> 19138292

Pharmacokinetics of cisplatin and methotrexate after M-VAC chemotherapy for advanced urothelial cancer in hemodialysis patients.

Kazuhiro Matsumoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19138292     DOI： 10.1111/j.1442-2042.2008.02123.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN： 0919-8172            Impact factor:   3.369


× No keyword cloud information.
  3 in total

1.  Simultaneous chemoradiation with cisplatin in a patient with recurrent cervical cancer undergoing hemodialysis: analysis of cisplatin concentrations in serum and dialysate and therapy-related acute toxicity.

Authors:  Simone Marnitz; Ralph Kettritz; Andreas Kahl; Silvia Lehenbauer-Dehm; Leonie Förster; Volker Budach; Christhardt Köhler
Journal:  Strahlenther Onkol       Date:  2011-11-25       Impact factor: 3.621

2.  Successful treatment of metastatic urothelial carcinoma arising in a transplanted renal allograft with paclitaxel, cisplatin, and gemcitabine combination therapy: a case report.

Authors:  Yasuyuki Kojima; Yuko Takahi; Naotsugu Ichimaru; Masayoshi Okumi; Shiro Takahara; Norio Nonomura
Journal:  BMC Res Notes       Date:  2015-02-04

3.  Safety of adjuvant gemcitabine plus cisplatin chemotherapy in a patient with bilateral ureteral cancer undergoing hemodialysis.

Authors:  Yumiko Goto; Kent Kanao; Kazuhiro Matsumoto; Ikuo Kobayashi; Keishi Kajikawa; Masafumi Onishi
Journal:  Int Cancer Conf J       Date:  2021-04-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.